T HE U NIVERSITY OF N EW M EXICO ▪ H EALTH S CIENCES C ENTER. Exploratory IND Studies. Michael Briggs, Operations Director Human Research Protections [email protected] 272-1147. August 2006. Topics. General Overview of IND Types & Components Focus on “ Exploratory IND”
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Clinical exploratory approach to enable sponsors to more efficiently identify and develop promising compounds under an IND, based on a more limited preclinical data set than that required for a traditional Phase 1 study.
Depending on type of study (3 examples)
Repeat Dose Toxicity (repeat dosing “ok” if separated by 1 week)
Not required for ExpIND
Note: Seek guidance from M.Briggs relating to GMP/GLP issues when planning IND study.